"Healthy Actions and Lifestyles to Avoid Dementia or Hispanos y el ALTo a la Demencia Program"
HALT-AD
A Pilot Study for the Healthy Actions and Lifestyles to Avoid Dementia or Hispanos y el ALTo a la Demencia Program (HALT-AD)
1 other identifier
interventional
20
1 country
1
Brief Summary
A Pilot Study for the Healthy Actions and Lifestyles to Avoid Dementia or Hispanos y el ALTo a la Demencia program (HALT-AD). This initial four-months pilot study will focus on at least three educational courses (introduction to dementia and lifestyle risk factors, sleep and diet). It may also include a fourth educational course on social connectivity and loneliness. Completion of this initial pilot study will allow for a round of improvements informed by data from the program, on usability, as well as feedback from participants and citizen advisors. This will allow for an iterative process to build the program to its full content, with feedback to optimize the user experience and ensure the accessibility of the content. The information generated from this study will help inform the development of the second program's prototype, expected to benefit from the initial pilot to become more user-friendly, effective and accessible to the target audience. This pilot study will be a longitudinal study of an inception cohort exposed to the HALT-AD online educational program for a four-month study. It will utilize pre- and post- intervention collection of quantitative and qualitative data to evaluate the program's first prototype.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable
Started Apr 2022
Shorter than P25 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
April 5, 2022
CompletedFirst Submitted
Initial submission to the registry
April 6, 2022
CompletedFirst Posted
Study publicly available on registry
April 28, 2022
CompletedPrimary Completion
Last participant's last visit for primary outcome
August 24, 2022
CompletedStudy Completion
Last participant's last visit for all outcomes
August 24, 2022
CompletedResults Posted
Study results publicly available
August 15, 2024
CompletedAugust 15, 2024
July 1, 2023
5 months
April 6, 2022
July 27, 2023
March 14, 2024
Conditions
Keywords
Outcome Measures
Primary Outcomes (2)
Users' Engagement With the HALT-AD Online Platform by Measuring the Total Amount of Time (in Minutes) Spent Per User on All Courses Combined
User engagement with the HALT-AD online platform by measuring the average total amount of time (in minutes) spent per user on all courses combined
4 months
Users' Engagement With the HALT-AD Online Platform by Measuring the Percentage of Participants Who Completed All Courses.
Users' engagement with the HALT-AD online platform by measuring the percentage of participants who completed all courses.
4 months
Secondary Outcomes (3)
Change From Baseline in Knowledge on the HALT-AD Knowledge Assessment Survey at 4 Months
at baseline and 4 months
Change From Baseline in Self-efficacy on the New General Self-Efficacy Scale (NGSE) at 4 Months.
at baseline and 4 months
Change From Baseline in Lifestyle Risk on the HALT-AD Lifestyle Risk Assessment Survey at 4 Months
at baseline and 4 months
Other Outcomes (5)
Acceptability Survey- Users' Acceptability of the HALT-AD Program Content
completed at 4 months
FOCUS Group Discussion- Qualitative Evaluation of the HALT-AD Program Content
4 months
Users' Satisfaction With the Facilitated Support Discussion Groups
4 months
- +2 more other outcomes
Study Arms (1)
HALT-AD
EXPERIMENTALHALT-AD is an online educational program designed to teach about dementia and lifestyle changes that can help preserve brain health and lower dementia risk. Participants complete online courses and engage in facilitated discussion groups.
Interventions
HALT-AD is an online educational program designed to teach about dementia and lifestyle changes that can help preserve brain health and lower dementia risk. Participants complete online courses and engage in facilitated discussion groups.
Eligibility Criteria
You may qualify if:
- Signed informed consent must be obtained and documented (from the participant).
- Sufficient proficiency in English or Spanish to undergo clinical assessment and participate in an online educational program.
- Ages 50-85
- Montreal Cognitive Assessment-Telephone/Blind Version (T-MoCA) score ≥18/22
- Technical ability to participate in an online educational program (i.e. ability to operate a computer/tablet and gain internet access; ability to send and receive emails)
- Sufficient vision and hearing to participate in online educational program (judgement of site investigator)
- Ability to sit comfortably for a period of at least 30 minutes
You may not qualify if:
- Participants who, in the opinion of the co-PIs, are not able to complete trial procedures or adhere to the schedule of study assessments will be excluded from study participation.
- Individuals where English or Spanish is not sufficiently proficient for clinical assessment, and participation in a web-based educational program.
- Participants who do not have sufficient vision and hearing to participate in an online educational program
- Individuals who do not have the technical ability to participate in an online educational program. Technical ability is defined as ability to operate a computer/tablet and gain internet access; ability to send and receive emails)
- Total Score on the T-MoCA \<18
- Individuals who have an advanced degree (e.g. Master's, MD, PhD) in an area related to brain health will not be eligible to participate.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Alzheimer's Disease Cooperative Study (ADCS)
La Jolla, California, 92037, United States
Related Publications (14)
Ostergren JE, Heeringa SG, Leon CFM, Connell CM, Roberts JS. The Influence of Psychosocial and Cognitive Factors on Perceived Threat of Alzheimer's Disease. Am J Alzheimers Dis Other Demen. 2017 Aug;32(5):289-299. doi: 10.1177/1533317517714552. Epub 2017 Jun 13.
PMID: 28605999BACKGROUND2020 Alzheimer's disease facts and figures. Alzheimers Dement. 2020 Mar 10. doi: 10.1002/alz.12068. Online ahead of print.
PMID: 32157811BACKGROUNDHurd MD, Martorell P, Delavande A, Mullen KJ, Langa KM. Monetary costs of dementia in the United States. N Engl J Med. 2013 Apr 4;368(14):1326-34. doi: 10.1056/NEJMsa1204629.
PMID: 23550670BACKGROUNDAgency, C.o.S.D.H.a.H.S., The Alzheimer's Project Clinical Rountable. Alzheimer's disease and related dementias in San Diego county. 2018.
BACKGROUNDLiving, A.f.C., Profile of Older Americans. 2019.
BACKGROUNDNetwork, U.E.R.R.I.o.A.L.s., Latinos and Alzheimer's Disease: New Numbers Behind the Crisis. 2016.
BACKGROUNDVelasco-Mondragon E, Jimenez A, Palladino-Davis AG, Davis D, Escamilla-Cejudo JA. Hispanic health in the USA: a scoping review of the literature. Public Health Rev. 2016 Dec 7;37:31. doi: 10.1186/s40985-016-0043-2. eCollection 2016.
PMID: 29450072BACKGROUNDCummings J, Lee G, Ritter A, Zhong K. Alzheimer's disease drug development pipeline: 2018. Alzheimers Dement (N Y). 2018 May 3;4:195-214. doi: 10.1016/j.trci.2018.03.009. eCollection 2018.
PMID: 29955663BACKGROUNDLivingston G, Sommerlad A, Orgeta V, Costafreda SG, Huntley J, Ames D, Ballard C, Banerjee S, Burns A, Cohen-Mansfield J, Cooper C, Fox N, Gitlin LN, Howard R, Kales HC, Larson EB, Ritchie K, Rockwood K, Sampson EL, Samus Q, Schneider LS, Selbaek G, Teri L, Mukadam N. Dementia prevention, intervention, and care. Lancet. 2017 Dec 16;390(10113):2673-2734. doi: 10.1016/S0140-6736(17)31363-6. Epub 2017 Jul 20. No abstract available.
PMID: 28735855BACKGROUNDKivipelto M, Solomon A, Ahtiluoto S, Ngandu T, Lehtisalo J, Antikainen R, Backman L, Hanninen T, Jula A, Laatikainen T, Lindstrom J, Mangialasche F, Nissinen A, Paajanen T, Pajala S, Peltonen M, Rauramaa R, Stigsdotter-Neely A, Strandberg T, Tuomilehto J, Soininen H. The Finnish Geriatric Intervention Study to Prevent Cognitive Impairment and Disability (FINGER): study design and progress. Alzheimers Dement. 2013 Nov;9(6):657-65. doi: 10.1016/j.jalz.2012.09.012. Epub 2013 Jan 17.
PMID: 23332672BACKGROUNDCummings J, Reiber C, Kumar P. The price of progress: Funding and financing Alzheimer's disease drug development. Alzheimers Dement (N Y). 2018 Jun 13;4:330-343. doi: 10.1016/j.trci.2018.04.008. eCollection 2018.
PMID: 30175227BACKGROUNDPendlebury ST, Welch SJ, Cuthbertson FC, Mariz J, Mehta Z, Rothwell PM. Telephone assessment of cognition after transient ischemic attack and stroke: modified telephone interview of cognitive status and telephone Montreal Cognitive Assessment versus face-to-face Montreal Cognitive Assessment and neuropsychological battery. Stroke. 2013 Jan;44(1):227-9. doi: 10.1161/STROKEAHA.112.673384. Epub 2012 Nov 8.
PMID: 23138443BACKGROUNDChen, G., S.M. Gully, and D. Eden, Validation of a new general self-efficacy scale. Organizational research methods, 2001. 4(1): p. 62-83.
BACKGROUNDMetlife Foundation. What America Thinks - Metlife Foundation Alzheimer's Survey. Available at: https://www.metlife.com/content/dam/microsites/about/corporateprofile/ alzheimers-2011.pdf. 2011.
BACKGROUND
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Results Point of Contact
- Title
- Sara Moukarzel, PhD, Program Manager
- Organization
- Alzheimer's Disease Cooperative Study
Study Officials
- STUDY DIRECTOR
Howard Feldman, MDCM FRCP(C)
Alzheimer's Disease Cooperative Study (ADCS)
- PRINCIPAL INVESTIGATOR
Sarah Banks, PhD, ABPP-CN
Alzheimer's Disease Cooperative Study (ADCS)
Publication Agreements
- PI is Sponsor Employee
- No
- Restrictive Agreement
- No
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Purpose
- OTHER
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
April 6, 2022
First Posted
April 28, 2022
Study Start
April 5, 2022
Primary Completion
August 24, 2022
Study Completion
August 24, 2022
Last Updated
August 15, 2024
Results First Posted
August 15, 2024
Record last verified: 2023-07
Data Sharing
- IPD Sharing
- Will not share